A high-throughput small molecule screen identifies farrerol as a potentiator of CRISPR/Cas9-mediated genome editing.

Journal: eLife

Published: 2020-07-09

DOI: 10.7554/elife.56008

Affiliations: 5

Authors: 14

Go to article
Institutions Share
Shanghai First Maternity and Infant Hospital Corporation, China 0.30
Shanghai Key Laboratory of Signaling and Disease Research, Tongji University, China 0.30
MOE Frontier Science Center for Stem Cell Research, Tongji University, China 0.30
State Key Laboratory of Natural Medicines (SKLNM), CPU, China 0.07
Tsingtao Advanced Research Institute, Tongji University, China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER